235 related articles for article (PubMed ID: 28704778)
1. Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson's disease, especially on bradykinesia.
Liu H; Su W; Li S; Du W; Ma X; Jin Y; Li K; Chen H
Clin Neurol Neurosurg; 2017 Sep; 160():101-104. PubMed ID: 28704778
[TBL] [Abstract][Full Text] [Related]
2. Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease.
Hashim H; Azmin S; Razlan H; Yahya NW; Tan HJ; Manaf MR; Ibrahim NM
PLoS One; 2014; 9(11):e112330. PubMed ID: 25411976
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial.
Tan AH; Lim SY; Mahadeva S; Loke MF; Tan JY; Ang BH; Chin KP; Mohammad Adnan AF; Ong SMC; Ibrahim AI; Zulkifli N; Lee JK; Lim WT; Teo YT; Kok YL; Ng TY; Tan AGS; Zulkifle IM; Ng CK; Ee SS; Arafin S; Mohamad Shukori K; Vadivelu JS; Marras C; Fox SH; Lang AE
Mov Disord; 2020 Dec; 35(12):2250-2260. PubMed ID: 32894625
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
Lee WY; Yoon WT; Shin HY; Jeon SH; Rhee PL
Mov Disord; 2008 Sep; 23(12):1696-700. PubMed ID: 18649391
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
Lolekha P; Sriphanom T; Vilaichone RK
PLoS One; 2021; 16(5):e0251042. PubMed ID: 33945559
[TBL] [Abstract][Full Text] [Related]
6. H. pylori and Parkinson's disease: Meta-analyses including clinical severity.
Dardiotis E; Tsouris Z; Mentis AA; Siokas V; Michalopoulou A; Sokratous M; Dastamani M; Bogdanos DP; Deretzi G; Kountouras J
Clin Neurol Neurosurg; 2018 Dec; 175():16-24. PubMed ID: 30308319
[TBL] [Abstract][Full Text] [Related]
7. Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial.
Chen KY; Lin TJ; Lin CL; Lee HC; Wang CK; Wu DC
World J Gastroenterol; 2015 Sep; 21(36):10435-42. PubMed ID: 26420970
[TBL] [Abstract][Full Text] [Related]
8. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
[TBL] [Abstract][Full Text] [Related]
10. Eradication Rate of
Liu RP; Romero R; Sarosiek J; Dodoo C; Dwivedi AK; Zuckerman MJ
South Med J; 2018 Jan; 111(1):51-55. PubMed ID: 29298370
[TBL] [Abstract][Full Text] [Related]
11. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386
[TBL] [Abstract][Full Text] [Related]
12. Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication.
Mansour-Ghanaei F; Joukar F; Naghipour MR; Forouhari A; Saadat SM
World J Gastroenterol; 2015 Jan; 21(2):661-6. PubMed ID: 25593496
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 May; 21(18):5568-74. PubMed ID: 25987781
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial surveillance in idiopathic parkinsonism: indication-specific improvement in hypokinesia following Helicobacter pylori eradication and non-specific effect of antimicrobials for other indications in worsening rigidity.
Dobbs SM; Charlett A; Dobbs RJ; Weller C; Iguodala O; Smee C; Lawson AJ; Taylor D; Bjarnason I
Helicobacter; 2013 Jun; 18(3):187-96. PubMed ID: 23336966
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection is associated with worse severity of Parkinson's disease.
Tan AH; Mahadeva S; Marras C; Thalha AM; Kiew CK; Yeat CM; Ng SW; Ang SP; Chow SK; Loke MF; Vadivelu JS; Ibrahim N; Yong HS; Tan CT; Fox SH; Lang AE; Lim SY
Parkinsonism Relat Disord; 2015 Mar; 21(3):221-5. PubMed ID: 25560322
[TBL] [Abstract][Full Text] [Related]
16. Effects of Helicobacter pylori on Levodopa Pharmacokinetics.
Nyholm D; Hellström PM
J Parkinsons Dis; 2021; 11(1):61-69. PubMed ID: 33164946
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.
Lim JH; Lee DH; Lee ST; Kim N; Park YS; Shin CM; Song IS
World J Gastroenterol; 2015 Dec; 21(46):13124-31. PubMed ID: 26673999
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication for Parkinson's disease.
Rees K; Stowe R; Patel S; Ives N; Breen K; Clarke CE; Ben-Shlomo Y
Cochrane Database Syst Rev; 2011 Nov; (11):CD008453. PubMed ID: 22071847
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
